Materials • Major Chemicals
$783.66 ▼ -19.41
(-2.42%)
MKT CAP: $7.39B • VOL: 198.1K
52W L $580 52W H $982
NEU // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2025-12-31 | FY 2024
FILED 2024-12-31 | FY 2023
FILED 2023-12-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.73B | $2.79B | $2.70B |
| YoY Revenue Growth % | -2.2% | +3.3% | — |
| Gross Profit | $857.4M | $886.3M | — |
| Gross Margin % | 31.5% | 31.8% | — |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $543.7M | $590.0M | $483.0M |
| Operating Margin % | 20.0% | 21.2% | 17.9% |
| Net Income (GAAP) | $418.7M | $462.4M | $388.9M |
| EBITDA (Normalized) | $605.8M | $635.9M | $580.2M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $569.0M | $519.6M | $576.8M |
| Capital Expenditures (CapEx) | $77.6M | $57.3M | $121.4M |
| Free Cash Flow (FCF) | $491.3M | $462.3M | $455.4M |
| FCF Margin % | 18.0% | 16.6% | 16.9% |
| Return on Invested Capital (ROIC %) | 16.6% | 19.8% | 15.6% |
| Cash & Short-Term Equivalents | $77.6M | $77.5M | — |
| Total Debt (Short + Long Term) | $883.4M | $971.3M | $950.5M |
| Total Stockholders' Equity | $1.78B | $1.46B | $1.95B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR NEU.